Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Princess Beatrix Fund, The Netherlands |
---|---|
Information provided by: | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
ClinicalTrials.gov Identifier: | NCT00272246 |
Primary generalized dystonia, also called idiopathic torsion dystonia or dystonia musculorum deformans is a disabling neurological condition which usually starts in childhood, mostly in a lower limb and spreads to other body parts as the disease progresses. Medical treatment is usually ineffective and most patients become wheelchair bound or even bedridden. Recently several case series and one RCT reported favourable results of bilateral deep brain stimulation (DBS) of the globus pallidus internus (GPi) for primary generalized dystonias.
However, the number of patients treated with bilateral GPi stimulation is still limited. Therefore, we propose a RCT to investigate whether bilateral DBS of the GPi is an effective and safe treatment in patients with primary generalized dystonia.
Condition | Intervention | Phase |
---|---|---|
Dystonia Primary Generalized Dystonia |
Procedure: deep brain stimulation of the internal globus pallidus |
Phase II Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study |
Estimated Enrollment: | 24 |
Study Start Date: | February 2005 |
Estimated Study Completion Date: | December 2007 |
Study design and methods:
This is a randomised, double-blind, placebo-controlled, multicentre study comparing the effect of bilateral DBS of the GPi with placebo in patients with invalidating primary generalized dystonia. After inclusion in the study (see in/exclusioncriteria), a preoperative formal baseline assessment is performed. Within six weeks after the inclusion the patients undergo the stereotactic implantation of the stimulation equipment in the GPi. Immediately after surgery the patients are randomly allocated to direct stimulation (treatment group) or delayed stimulation (control group), in which the stimulator will se switched on 0 Volt before discharge from the hospital by an independent neurologist or neurosurgeon. The patients in both groups are able to control whether the stimulation is active (>0 Volt) or not. In this way the patients and the assessors are blinded. In each centre the postoperative care of the patients will take place according to a stratified stimulation parameter protocol which assures comparable information in both groups. Six months postoperatively, the first formal outcome assessment is performed by the same blinded assessor. After completion of this assessment the stimulators in the control group are activated by an independent neurologist or neurosurgeon. From this moment, all 24 patients have active DBS.
However, the patients and blinded assessor remain unaware of the result of the randomisation. All patients are followed for another six months after which the second outcome assessment is made by the same assessor. Four Dutch centres experienced in DBS have agreed to participate in the study. It is estimated that each centre will include at least 4 patients. Because these centra are geographically spread over the country patients can be operated and controlled nearby.
Ages Eligible for Study: | 12 Years to 60 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Elisabeth MJ Foncke, MD | 0031205669111 ext 58966 | e.m.foncke@amc.uva.nl |
Contact: Hans Speelman, MD,PhD | 0031205669111 ext 63963 | j.d.speelman@amc.uva.nl |
Netherlands | |
Department of Neurology, Movement Disorders Center | Recruiting |
Amsterdam, Netherlands, 1100 DD | |
Contact: Elisabeth MJ Foncke, MD 0031205669111 ext 58966 e.m.foncke@amc.uva.nl | |
Principal Investigator: Elisabeth MJ Foncke, MD |
Study Chair: | Hans Speelman, PhD | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
Study ID Numbers: | DYSPAS |
Study First Received: | January 4, 2006 |
Last Updated: | January 4, 2006 |
ClinicalTrials.gov Identifier: | NCT00272246 History of Changes |
Health Authority: | Netherlands: Medical Ethics Review Committee (METC) |
dystonia |
Dystonic Disorders Signs and Symptoms Movement Disorders Central Nervous System Diseases |
Neurologic Manifestations Dystonia Dyskinesias |
Dystonic Disorders Signs and Symptoms Movement Disorders Nervous System Diseases |
Central Nervous System Diseases Neurologic Manifestations Dystonia Dyskinesias |